The relationship between PARP inhibitors with the relapse and leukemisation of lymphomas: a case report

BACKGROUND: Nowadays the poly-ADP ribose polymerase inhibitors (iPARPs) are the mainly treatment for the ovarian cancer and other solid tumours. However, given its recent use, long-term toxicity is still under study. The occurrence of acute leukaemias and myelodysplastic syndromes (MDS) secondarily...

Descripción completa

Detalles Bibliográficos
Autores principales: Navalón-Jiménez, Marta, Olivares-Hernández, Alejandro, Figuero-Pérez, Luis, Miramontes-González, José Pablo, Montero-Mateos, Enrique, Cruz-Hernández, Juan Jesús, Fonseca-Sánchez, Emilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130682/
https://www.ncbi.nlm.nih.gov/pubmed/37122963
http://dx.doi.org/10.21037/acr-22-91

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130682/
https://www.ncbi.nlm.nih.gov/pubmed/37122963
http://dx.doi.org/10.21037/acr-22-91

Ejemplares similares